A Study to Evaluate the Efficacy and Safety of Arbaclofen Placarbil (XP19986) as Adjunctive Therapy in Subjects With Gastroesophageal Reflux Disease (GERD)

This study has been completed.

Study NCT00978016 Information provided by XenoPort, Inc.

First Received: September 11, 2009 Last Updated: January 27, 2012 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	December 2010
Primary Completion Date:	December 2010 (Final data collection date for primary outcome measure)
Certification - "Seeking Initial Approval":	Submission Date: January 25, 2012